An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

NCT07583953 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

BIOLOGICAL: ABO2109 Injection;Toripalimab
BIOLOGICAL: ABO2109 Injection;Toripalimab

Sponsor

Suzhou Abogen Biosciences Co., Ltd.

Collaborators

[object Object]